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Invasion and persistence of bacteria within host cells requires that they adapt to life in an intracellular 
environment. This adaptation induces bacterial stress through events such as phagocytosis and 
enhanced nutrient-restriction. During stress, bacteria synthesize a family of proteins known as 
heat shock proteins (HSPs) to facilitate adaptation and survival. Previously, we determined the 
Staphylococcus aureus HSP ClpC temporally alters bacterial metabolism and persistence. This led 
us to hypothesize that ClpC might alter intracellular survival. Inactivation of clpC in S. aureus strain 
DSM20231 significantly enhanced long-term intracellular survival in human epithelial (HaCaT) and 
endothelial (EA.hy926) cell lines, without markedly affecting adhesion or invasion. This phenotype was 
similar across a genetically diverse collection of S. aureus isolates, and was influenced by the toxin/
antitoxin encoding locus mazEF. Importantly, MazEF alters mRNA synthesis and/or stability of S. aureus 
virulence determinants, indicating ClpC may act through the mRNA modulatory activity of MazEF. 
Transcriptional analyses of total RNAs isolated from intracellular DSM20231 and isogenic clpC mutant 
cells identified alterations in transcription of α-toxin (hla), protein A (spa), and RNAIII, consistent with 
the hypothesis that ClpC negatively affects the intracellular survival of S. aureus in non-professional 
phagocytic cells, via modulation of MazEF and Agr.
The gram-positive bacterium Staphylococcus aureus is a common cause of persistent and relapsing infections1. 
These types of infections are hypothesized to be due to the formation of persister cells having reduced metabolic 
activity and virulence factor synthesis2. In addition, persistent and relapsing infections are thought to be aided 
by S. aureus ability to invade and survive in non-professional phagocytic cells3,4. Persistent S. aureus infections 
often involve the formation of small colony variants (SCV)s that have defects in electron transport and thymi-
dylate biosynthesis5, a process requiring the alternative sigma factor σB  6. During the study of S. aureus thyA 
mutants displaying an SCV phenotype, it was observed that transcription of the heat shock protein (HSP) ClpC, 
a ClpATPase encoded by clpC, was significantly reduced relative to the isogenic parental strain7. This observa-
tion raised the possibility that metabolic signals created by inactivating thyA are transduced into action through 
repression of ClpC activity.
While the function of the HSP ClpC on SCV formation is unclear, its role as an effector of staphylococcal 
energy metabolism, stress adaptation, and stationary phase survival is established8–10. These effects are mediated 
over a broad range of genes in the S. aureus transcriptome9,11, in concert with ClpC’s cognate protease ClpP and 
the proteolytic adaptor protein TrfA12. In addition to affecting transcription, ClpC alters the activity of toxin/
antitoxin systems in S. aureus by degrading antitoxins12,13, including the toxin/antitoxin system MazEF. MazF 
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represents a sequence specific RNase, while MazE is a cognate inhibitor of MazF and subject to proteolysis to 
activate MazF14. Interestingly, the MazEF toxin/antitoxin system affects intracellular survival of S. aureus in oste-
oblasts15. Taken together, the effect of ClpC on metabolism, survival, and MazEF, suggests that this HSP might 
affect intracellular persistence. This suggestion is supported by the observation that deletion of clpC in S. aureus 
strain 8325-4 decreased intracellular replication in bovine mammary epithelial cells16; of note, this study did not 
address S. aureus persistence. To assess the significance of ClpC in S. aureus intracellular persistence, bacterial 
long-term survival in keratinocytes and endothelial cells was examined.
Results and Discussion
S. aureus strain DSM20231 adheres to and is internalized by non-professional phagocytic 
cells. The invasion and persistence of S. aureus into eukaryotic cells are strongly dependent on the host cell 
type and the infecting S. aureus strain4. Persistence is an aggregate process that is dependent, in part, upon the 
bacterial abilities to adhere and be internalized by host cells. Alterations in the ability to adhere or invade would 
complicate the assessment of bacterial persistence. To eliminate the possibility that differences in persistence were 
due to changes in the competence of bacteria to adhere or be internalized, strain DSM20231 (syn. ATCC 12600), a 
S. aureus derivative of the type strain 533 R4 isolated from human pleural fluid, and known to exert a strong ClpC 
effect on stationary phase survival8, was assessed for its ability to adhere to and invade HaCaT and Ea.hy926 cells. 
When strain DSM20231 and its clpC derivatives were brought into contact with keratinocytes or endothelial cells 
by mild centrifugation, about one fifth of the bacteria remained associated with the eukaryotic cells after 90 min of 
co-incubation and washing (Fig. 1a), suggesting that bacterial adhesion to eukaryotic cells is largely independent 
of ClpC in S. aureus. To gain additional insights into the effect of ClpC on adhesion of S. aureus to eukaryotic cells 
at the single cell level, adhesion of strains DSM20231 and PBM001 to Ea.hy926 cells was also analyzed by single 
cell force spectroscopy (SCFS). In this method, a viable cell (here a single bacterium) is immobilized on the tip 
of an atomic force microscope (AFM) cantilever to create a bacterial probe. This bacterial probe is brought into 
physical contact with its substratum (here the extracellular matrix [ECM] of an epithelial cell), and after a certain 
contact time the bacterial probe is withdrawn to rupture the potentially formed bacterium-ECM interactions. The 
rupture force and rupture length are detected by the deflection of the AFM cantilever, which allows studying the 
interaction forces between a single bacterium and its substratum with nanometer spatial and piconewton force 
resolution17. Similar to the adhesion assays (Fig. 1a), the interaction forces between single bacteria and Ea.hy926 
cells were comparable (Fig. 1b–d, Table S1). These data strongly suggest that S. aureus adhesion to eukaryotic cells 
is independent of ClpC and will not interfere with persistence assays. The adherence of strain DSM20231 and its 
mutant derivatives to HaCaT and Ea.hy926 cells was equivalent, but this does not rule out the possibility that dif-
ferences in internalization could alter persistence. To address this possibility, lysostaphin/gentamicin protection 
assays were used. Strain DSM20231 invaded both cell lines in a bacterial cell density-dependent manner (Fig. 2a). 
While increasing the multiplicity of infection (MoI) enhanced bacterial invasion, invasion was not proportional 
to the increased number of bacteria (Fig. 2a), suggesting that the uptake process can be saturated at high MoIs. 
At a high MoI, bacterial cytotoxicity can kill eukaryotic cell lines. To exclude this possibility, cell viability was 
assessed using propidium iodide (PI) following bacterial invasion. Neither HaCaT nor EA.hy926 cells displayed 
increased cell death rates at 24 post infection with S. aureus strain DSM20231 (Fig. 2b), a result similar to that 
reported for S. aureus strains USA300, SH1000 and Cowan I4. Together, these results demonstrate that S. aureus 
strain DSM20231 can be reliably used in HaCaT and EA.hy926 cell lines for invasion and persistence assays.
S. aureus cytotoxicity is independent of ClpC. To determine if ClpC affects invasion of keratino-
cytes and endothelial cells through altered cytotoxicity, HaCaT and EA.hy926 cells were challenged with strains 
DSM20231, PBM001, and the clpC complemented PBM001 derivative, and the cells were detached and viability 
was assessed by propidium iodide (PI) staining. All three strains were internalized into HaCaT or EA.hy926 cells 
with comparable efficiencies and equivalent numbers of cells retained the PI stain (Fig. 3a, c, 0 h). To determine 
the cytotoxic effects of S. aureus infection in these eukaryotic cell lines, MTT (3-[4.5-dimethylthiazol-2-yl]-2
.5-diphenyltetrazolium bromide) based cell viability assays were performed. The metabolic activities of strain 
DSM20231 and PBM001 infected HaCaT cultures, at 96 h and 168 h post-infection, were equivalent to those of 
the controls (Fig. S1), indicating that the viability of this keratinocyte cell line is not markedly affected by the 
intracellular persisting S. aureus cells. EA.hy926 cultures infected with strains DSM20231 and PBM001, however, 
decreased cell metabolism later during persistence (i.e., 96 h and 168 h post infection) relative to the bacteria-free 
controls (Fig. S1b). Taken together, these data indicate that ClpC is not required for internalization and that it 
minimally alters cytotoxicity to non-professional phagocytic cells.
Deletion of clpC in S. aureus enhances intracellular survival in keratinocytes and endothelial 
cells. The absence of differences in adhesion, internalization, and toxicity associated with ClpC allowed us to 
assess intracellular persistence without complicating circumstances. To do this, intracellular bacterial cell densi-
ties were determined at 24 h, 96 h, and 168 h post-infection of HaCaT and EA.hy926 cells (Fig. 3). Within 24 h of 
internalization, HaCaT cells killed approximately 75% of the intracellular bacteria, irrespective of the presence 
of ClpC (Figs 3a, b). Similar results were obtained with EA.hy926 cells (Figs 3c, d). Interestingly, after 96 h and 
168 h of cultivation, significantly greater numbers of viable bacteria were present in both HaCaT (5.2-fold and 
20.3-fold, respectively) and EA.hy926 cells (3.2-fold and 24.9-fold, respectively) infected with the clpC mutant 
strain PBM001 relative to those infected with the wild-type strain. Complementation of clpC restored persistence 
to near wild-type levels (Fig. 3).
The ability of S. aureus to persist in non-professional phagocytes can be affected by the bacterial genetic back-
ground4. To exclude that the intracellular survival phenotype attributed to ClpC is unique to strain DSM20231, 
the clpC mutation was transduced into S. aureus strains LS1, Newman, and SH1000, and persistence was assessed. 
3Scientific RepoRtS |         (2019) 9:16267  | https://doi.org/10.1038/s41598-019-52731-3
www.nature.com/scientificreportswww.nature.com/scientificreports/
Irrespective of the genetic background, inactivation of clpC did not alter internalization of S. aureus (Fig. 4) or 
survival during the first 24 h post-infection. At 96 h post-infection all clpC mutants maintained significantly 
greater bacterial numbers than did the isogenic wild-type strains in HaCaT, while significantly increased cell 
numbers were observed in EA.hy926 cells after 168 h post-infection. Taken together, these data demonstrate that 
clpC inactivation enhances persistence in keratinocytes and endothelial cells and is unrelated to the strain back-
ground. These observations are consistent with ClpC activity being greatest late in the growth cycle of S. aureus9.
SCV formation by intracellularly persisting S. aureus is independent of ClpC. Earlier work 
demonstrated that intracellular passage of S. aureus in eukaryotic cells enhances SCV formation6,18. To assess 
whether ClpC enhances persistence of S. aureus via augmentation of SCV formation, we determined the ratios 
of SCVs formed in EA.hy926 cells after 168 h post-infection (Fig. S2). Consistent with other S. aureus genetic 
lineages6,18, strain DSM20231 produced SCVs upon intracellular passage (3.3 ± 1.5% of colonies with a colony 
area ≤10 than the average colony area of normal growing colonies). The clpC mutant PBM001 produced a slightly 
higher ratio of SCVs upon intracellular passage (4.5 ± 1.4%); however, this difference was not statistically signif-
icant (P = 0.242, Mann-Whitney U test). These findings suggest that the increased intracellular survival capacity 
of PBM001 in non-professional phagocytic cells is not due to an increased ability to form SCVs.
Figure 1. Adhesion capacities of S. aureus DSM20231 and its clpC derivatives to non-professional phagocytes. 
(a) HaCaT and Ea.hy926 cells were challenged with the S. aureus strains DSM20231 (WT; black bars), the clpC 
mutant PBM001 (clpC; white bars), and the clpC complemented PBM001 derivative (clpC/clpC+, grey bars) at 
a MoI of 100, respectively, and co-cultured for 90 min. Non-adherent bacteria were subsequently removed by 
washing. Eukaryotic cells were afterwards lysed by sonication, and CFU rates in lysates determined by plate 
counting. Data are presented as mean + SD (n = 6 biological replicates). ns, not significant (Kruskal Wallis test 
followed by Dunn’s post-hoc test). (b–d) Single cell force spectroscopy of DSM20231 (black bars) and PBM001 
(white bars) cells on Ea.hy926 cells. (b) Representative retraction force profiles obtained by recording force-
distance curves in DMEM between bacteria and Ea.hy926 cells spread on glass bottom petri dishes for 24 h. 
(c,d) Maximum adhesion force- and rupture length histograms. Histograms are from a total of 320 curves from 
5 independent cell pairs per bacterial strain. They were obtained by determining, for each curve, the force of the 
strongest adhesive event (c) and the distance of the last rupture event (d). ns, not significant (Mann-Whitney U 
test).
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ClpC enhanced intracellular survival of S. aureus requires MazEF. ClpCP modulates the activity of 
the MazEF toxin/antitoxin system by degrading the antitoxin, MazE, in a growth phase-dependent manner12,13. 
Additionally, MazEF alters the intracellular survival of S. aureus in osteoblasts15, suggesting that ClpC might affect 
the intracellular survival of S. aureus through MazEF. To test this hypothesis, we created mazEF mutants in strains 
DSM20231 and PBM001 and assessed their ability to survive intracellularly (Fig. 5). Similar to strain DSM20231, 
all three derivatives had comparable numbers of internalized bacteria after 90 min of incubation with HaCaT 
and Ea.hy926 cells. As expected, we observed that strain PBM001 had significantly increased numbers of viable 
bacteria in HaCaT (Fig. 5a) or Ea.hy926 (Fig. 5b) cells after 168 h of cultivation relative to the wild-type strain. 
Deletion of mazEF in DSM20231 did not markedly alter the invasion and intracellular survival of the mutant in 
keratinocytes and endothelial cells. At 168 h post lysostaphin/gentamicin treatment, the mazEF deletion strain 
had reduced numbers of intracellularly surviving bacteria in HaCaT cells, however this was not statistical signif-
icant (P = 0.124, Mann-Whitney U test between WT and mazEF mutant). These findings are in contrast to those 
made by Kolenda and colleagues15, where deletion of mazEF in strain HG003 enhanced intracellular survival in 
osteoblasts at 24 and 48 h post infection. Interestingly, in the clpC mazEF double mutant, the numbers of surviv-
ing bacteria were equivalent to those of strain DSM20231 at all time points, indicating that PBM001 required an 
intact mazEF locus to augment its intracellular persistence in HaCaT and Ea.hy926 cells. Taken together, these 
data suggest that ClpC influences S. aureus intracellular survival in keratinocytes and endothelial cells, in part, 
via the modulation of MazEF activity.
Figure 2. Impact of the MoI on the capacity of S. aureus DSM20231 to internalize non-professional phagocytes 
and cytotoxic potential of DSM20231 and its clpC derivatives on keratinocytes and endothelial cells. (a) 
Cells of the keratinocyte cell line HaCaT and the endothelial cell line Ea.hy926 were infected with S. aureus 
DSM20231 at MoIs of 1, 10, and 100, respectively, and co-cultured for 90 min. Extracellular and adherent 
bacteria were subsequently removed by washing and lysostaphin/gentamicin treatment, the eukaryotic cells 
lysed by sonication, and surviving bacteria in lysates determined by plate counting. Data are presented as 
box and whisker plot showing the interquartile range (25–75%; box), median (horizontal line), and whiskers 
(bars; min/max). (n = 6 biological replicates). (b) Eukaryotic cells were challenged with the S. aureus strains 
DSM20231 (WT; black bars), the clpC mutant PBM001 (clpC; white bars), and the clpC complemented PBM001 
derivative (clpC/clpC+, grey bars) at a MoI of 100 and co-cultured for 90 min. Extracellular and adherent 
bacteria were subsequently removed by washing and lysostaphin/gentamicin treatment, and infected cell lines 
and unchallenged control cells were cultured for 24 h in cell culture medium. PI-positive cells were identified by 
FACS as outlined in Materials. Data are presented as mean + SD (n = 6 biological replicates). ns, not significant 
(Kruskal Wallis test followed by Dunn’s post-hoc test).
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Inactivation of clpC alters the transcription of hla, RNAIII, and spa in vitro and in internalized bac-
teria. The pore-forming cytolysin α-toxin (encoded by hla) is an important virulence factor of S. aureus that is 
under multiple levels of control19. Deletion of hla in S. aureus enhances intracellular persistence in HaCaT cells20, 
and it inhibits apoptosis21. Interestingly, hla mRNA stability is decreased by MazF activity in strain Newman22, 
which is in part controlled by the ClpCP proteolytic complex13. Similarly, the stability of spa mRNA (protein A) 
is also affected by MazF activity in different S. aureus strains (Newman and HG003)22,23. These observations are 
important because transcription of both hla and spa are altered in SCVs and persister cells2. To assess if ClpC alters 
transcription of hla and spa, we used qRT-PCR to determine the mRNA levels of hla and spa in strains DSM20231 
and PBM001 both in vitro and after host cell invasion (Fig. 6). Consistent with previous observations24, during batch 
cultivation transcription of hla and spa was growth phase-dependent in strain DSM20231. Specifically, hla mRNA 
levels were most abundant late in the growth cycle (i.e., after 16 h of cultivation), while spa mRNA levels were ele-
vated early in the growth cycle (i.e., after 3 h of cultivation). Similarly, transcription of hla and spa were growth phase 
dependent in the clpC mutant, although, hla and spa mRNA levels were greater in the clpC mutant relative to the 
wild-type strain. This latter observation is consistent with ClpCP affecting the stability of hla and spa mRNAs via 
degradation of the antitoxin MazE. To assess the hla and spa mRNA levels in internalized bacteria, EA.hy926 cells 
were infected and total RNA was isolated and used for qRT-PCR. At 90 minutes post-infection, hla and spa mRNA 
Figure 3. Impact of ClpC on the intracellular survival of S. aureus DSM20231 in keratinocytes and endothelial 
cells. Cells of the keratinocyte cell line HaCaT (a, b) and the endothelial cell line Ea.hy926 (c, d) were infected 
with the S. aureus strains DSM20231 (WT; black bars), the clpC mutant PBM001 (clpC; white bars), and the 
clpC complemented PBM001 derivative (clpC/clpC+, grey bars) at a MoI of 100, respectively, and co-cultured 
for 90 min. Extracellular and adherent bacteria were subsequently removed by washing and lysostaphin/
gentamicin treatment, and the infected cell lines cultured for up to 168 h in cell culture medium supplemented 
with gentamicin. At 24, 96, and 168 h post lysostaphin/gentamicin treatment, eukaryotic cells were removed, 
lysed by sonication, and surviving bacteria in lysates determined by plate counting. (a, c) CFU rates recovered 
from infected HaCaT (a) and Ea.hy926 (c) lysates at the time points indicated. Data are presented as mean + SD 
(n = 8 biological replicates). (b, d) Relative survival (%) of intracellular bacteria in HaCaT (b) and Ea.hy926 
(d) cells in relation to the CFU rates seen immediately after the lysostaphin/gentamycin treatment. Data are 
presented in box and whisker plots (n = 8 biological replicates). *P < 0.05; **P < 0.01 (Kruskal Wallis test 
followed by Dunn’s post-hoc test). TpL/G, time post lysostaphin/gentamicin treatment. Horizontal dashed lines 
indicate the limit of detection.
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levels from internalized DSM20231 and PBM001 cells were equivalent between the wild-type and the clpC mutant. 
In contrast, after 96 h in EA.hy926 cells, clpC inactivated bacteria had significantly higher levels of spa mRNA, con-
sistent with the hypothesis that ClpC affects transcription of spa via the control of MazEF activity. However, for hla 
mRNA levels, significantly more hla mRNA was found in DSM20231 cells that persisted for 96 h in EA.hy926 cells 
relative to that found in the clpC mutant (Fig. 6a). Although this observation is consistent with the reduced survival 
of intracellular DSM20231 cells (Fig. 3), it is inconsistent with the indication that ClpC controls hla transcription 
primarily via the modulation of MazEF activity. That being said, since transcription of hla is under multiple levels of 
control19, it cannot be excluded that ClpC might promote hla transcription under these conditions via cooperation 
with other regulatory elements, such as CcpA, CodY, Rex, and AgrA25–28, all of which are substrates for ClpC in 
S. aureus29. One of the regulatory factors promoting hla transcription and being affected by ClpC is the response 
regulator AgrA of the agr locus27,29. To determine whether ClpC alters transcription of the agr locus, we assessed the 
transcript levels of RNAIII, the main effector molecule of the agr locus30, in strains DSM20231 and PBM001 in vitro 
and after host cell invasion (Fig. 6c). Consistent with previous observations, transcription of RNAIII was growth 
phase-dependent31. In batch culture grown DSM20231 cells, RNAIII transcript levels were low during exponential 
Figure 4. Impact of the strain background on the ClpC effect on intracellular survival of S. aureus in non-
professional phagocytes. HaCaT and EA.hy926 cells were infected with the S. aureus strains LS1 (a), Newman 
(b), SH1000 (c) (WT; black bars), and the isogenic clpC mutants (clpC; white bars) at a MoI of 100, respectively, 
and co-cultured for 90 min. Extracellular and adherent bacteria were subsequently removed by washing and 
lysostaphin/gentamicin treatment, and the infected cell lines cultured for up to 168 h in cell culture medium 
supplemented with gentamicin. At the time points indicated, cells were removed, lysed by sonication, and 
surviving bacteria in lysates determined by plate counting. Data are presented as mean + SD (n = 6 biological 
replicates). *P < 0.05; **P < 0.01 (Mann-Whitney U test between WT and isogenic clpC mutant at a given time 
point). TpL/G, time post lysostaphin/gentamicin treatment.
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growth (3 h), but increased in the later growth phase (16 h). In PBM001 cells, the clpC mutant produced a signifi-
cantly greater amount of RNAIII in the exponential growth phase, relative to that of wild-type bacteria. In contrast 
to the exponential growth phase level of RNAIII, after 16 h of cultivation, PBM001 cells had very little RNAIII. In 
short-time internalized bacteria (i.e. after 90 minutes post-infection), RNAIII levels in DSM20231 and PBM001 
cells were equivalent. In contrast, significantly more RNAIII was found in DSM20231 cells that persisted for 96 h in 
EA.hy926 cells relative to that found in the clpC mutant strain (Fig. 6c), suggesting that ClpC enhances transcription 
of hla in intracellularly persisting DSM20231 cells. The simplest explanation for these data is that ClpC enhances 
transcription of the agr locus, causing an increase in RNAIII transcription, which in turn increases hla transcription. 
However, alternative regulatory circuits cannot be excluded.
Concluding remarks. The ability of S. aureus to invade host cells and to persist intracellularly is considered 
a major contributor to its ability to cause chronic diseases. We show here that inactivation of clpC in S. aureus 
augments the long-term intracellular survival in non-professional phagocytes, suggesting that ClpC modulates 
intracellular persistence. This is likely mediated, at least in part, due to an interaction of ClpC with AgrA, and 
to the ClpCP mediated degradation of MazE. Degradation of MazE activates the site-specific endoribonuclease 
MazF13, thereby inducing bacterial cell stasis22.
Materials and Methods
Bacterial strains, plasmids and culture conditions. Eukaryotic cell lines, bacterial strains, and plasmids 
used in this study are listed in Table 1. Bacteria were routinely grown at 37 °C with 230 rpm of aeration in Brain Heart 
Infusion (BHI) broth or Luria Bertani (LB) broth purchased from Becton Dickinson (Heidelberg, Germany), using a 
culture medium-to-flask volume of 1:10. Where required, media were supplemented with (per milliliter): 10 µg erythro-
mycin, or 10 µg tetracycline. HaCaT cells were cultured in MCDB153 Basal Medium (Biochrom AG, Berlin, Germany), 
10% fetal bovine serum (FBS; PAA, Cölbel, Germany), and 1% non-essential amino acids (NEAA; Gibco, Darmstadt, 
Germany). EA.hy926 cells were cultivated in Dulbecco´s Modified Eagle Medium (Fisher Scientific, Schwerte, 
Germany) supplemented with 10% FBS. Both cell lines were grown in a humidified atmosphere at 37 °C and 5% CO2.
Figure 5. Impact of MazEF on the ClpC effect on intracellular survival of S. aureus DSM20231 in keratinocytes 
and endothelial cells. HaCaT (a) and EA.hy926 (b) cells were infected with the S. aureus strains DSM20231 
(WT; black bars), PBM001 (clpC; white bars), DSM20231 mazEF (mazEF; transversal dashed bars), and 
DSM20231 clpC mazEF (clpC mazEF; dotted bars) at a MoI of 100, respectively, and co-cultured for 90 min. 
Extracellular and adherent bacteria were subsequently removed by washing and lysostaphin/gentamicin 
treatment, and the infected cell lines cultured for up to 168 h in cell culture medium supplemented with 
gentamicin. At the time points indicated, cells were removed, lysed by sonication, and surviving bacteria 
in lysates determined by plate counting. Data are presented as mean + SD (n = 6–8 biological replicates). 
*P < 0.05; **P < 0.01 (Kruskal Wallis test followed by Dunn’s post-hoc test between WT and mutants at a given 
time point). TpL/G, time post lysostaphin/gentamicin treatment.
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Construction of clpC and mazEF mutants. S. aureus clpC mutants were obtained by transducing the 
resistance cassette tagged clpC mutation of PBM00132 into strains LS1, Newman, SH1000, and DSM20231 mazEF, 
using phage 85. The DSM20231 mazEF mutant was created using plasmid pBT2-mazEF-ko-ermB as described23. 
Figure 6. Impact of ClpC on the transcription of hla, spa, and RNAIII. Quantitative transcript analyses of 
hla (a), spa (b), and RNAIII (c) by qRT-PCR in DSM20231 (WT, black bars) and PBM001 (clpC, white bars) 
cells grown in BHI to the time points indicated or persisting intracellularly in Ea.hy926 cells for 90 min and 
96 h, respectively. Transcripts were quantified in reference to the transcription of gyrase B (in copies per copy 
of gyrB). Data are presented as mean + SD (n = 5–6 biological replicates). **P < 0.01 (Mann-Whitney U test 
between WT and mutant at a given time point). TpL/G, time post lysostaphin/gentamicin treatment.
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For cis-complementation of PBM001 with a functional clpC, a 1-kb DNA fragment containing the C-terminus 
of clpC, including the terminator sequence, was amplified by PCR from the chromosomal DNA of S. aureus 
strain N315 using the primer pair MBH325/MBH326 (Table 2). The resulting PCR product was digested with 
KpnI/XhoI, and subsequently cloned into the KpnI/XhoI-digested vector pBT33 to generate the suicide plasmid 
pBT_clpC’. The plasmid was transformed into S. aureus strain RN4220 and selected for tetracycline-resistance. 
A tetracycline-resistant RN4220 derivative that integrated pBT_clpC’ in its chromosome at the clpC locus was 
used as donor to transduce the tet(L)-tagged clpC allele into PBM001, thereby replacing the erm(B)-tagged clpC 
mutation with the tet(L)-tagged clpC allele. Restoration of the clpC wild-type gene in one of the transductants, 
PBM001 clpC+, was verified by DNA sequencing.
Single cell force spectroscopy. Adhesion of DSM20231 and its isogenic clpC mutant (PBM001) 
to endothelial cells was determined as follows: EA.hy926 cells (7.5 × 104 cells/petri dish) were seeded in 
glass-bottomed petri dishes (World Precision Instruments, Berlin, Germany) and allowed to adhere for 24 h in 
supplemented DMEM. Single, stationary phase cells (16 h of growth in LB), of strains DSM20231 and PBM001 
were attached to tipless cantilevers (MLCT-0; Bruker Nano, Santa Barbara, CA) and tested for viability as 
described17. Cantilevers were calibrated before each set of experiments, and bacterial probes were used to meas-
ure the interaction forces between the bacterial cell and Ea.hy926 cells at room temperature by recording 8 × 8 
force-distance curves on 1 × 1 µm lamellipodial areas of the cells. Force-distance curves were obtained in DMEM 
at room temperature with a Bioscope Catalyst atomic force microscope (Bruker) with a ramp size of 7 µm, a 
ramp velocity of 1 µm/s, a force trigger of 1 nN, and a surface delay time of 250 ms. Data were analyzed using the 
Nanoscope Analysis software (Bruker).
Adhesion, invasion and persistence assay. The adhesion, internalization and persistence assays were 
carried out as described34, with minor modifications. Briefly, EA.hy926 and HaCaT cells were grown for 24 hours 
in 24-well plates until confluent (~4.5 × 105 cells per well). Bacteria from overnight cultures were harvested by 
centrifugation, washed, and suspended in phosphate-buffered saline (PBS; Gibco). Eukaryotic cells were inocu-
lated with bacteria using a multiplicity of infection (MoI) of either 1, 10, or 100, centrifuged for 1 min at 1000 × g 
to promote attachment of bacteria to the cells, and subsequently co-cultivated for 90 min at 37 °C. Thereafter, wells 
were washed three times with PBS to remove unbound bacteria. Eukaryotic cells were then detached by adding 
0.5% Trypsin (Biochrom AG), and lysed by sonication at 50 W for 15 s in H2O, and colony-forming units (CFUs) 
were determined by plating dilutions of the lysates on sheep blood agar (BD). For the lysostaphin/gentamicin 
protection assays (internalization), adherent but not internalized bacterial cells were subsequently removed by 
incubating the bacteria-challenged cells for 1 h at 37 °C in appropriate culture media supplemented with 20 µg/
ml lysostaphin (Genmedics, Reutlingen, Germany) and 100 µg/ml gentamicin (Refobacin, Merck, Darmstadt, 
Strain/cell line Relevant genotype and phenotypea
Reference 
or source
Cell lines
EA.hy926 Hybrid cell line derived by fusing human umbilical vein endothelial cells with the permanent human cell line A549
35
HaCaT ‘Human adult low calcium high temperature keratinocytes’, spontaneously immortalized human keratinocyte cell line
36
S. aureus
DSM20231 Serovar 3 type strain, ATCC12600 37
DSM20231 mazEF DSM20231 mazEF::lox72 This study
DSM20231 mazEF clpC DSM20231 mazEF::lox72 clpC::erm(B); EmR This study
LS1 Murine arthritis isolate 38
LS1 clpC LS clpC::erm(B); EmR This study
Newman Clinical isolate (ATCC 25904) 39
Newman clpC Newman clpC::erm(B); EmR This study
PBM001 DSM20231 clpC::erm(B); EmR 32
PBM001 clpC+ PBM001 clpC::pBT_SACOL0570’, clpC+; TcR This study
RN4220 Restriction negative, modification positive NCTC 8325-4 derivative 40
SH1000 NCTC 8325-4 rsbU+ derivative 41
SH1000 clpC SH1000 clpC::erm(B); EmR This study
Plasmids
pBT pBC-SK derivative harboring an 1.6-kb PCR fragment of tet(L) from pHY300PLK cloned into the Alw26I restriction site; TcR
33
pBT_clpC’ pBT derivative harboring an 1-kb DNA fragment of the C-terminus of clpC; TcR This study
pBT2-mazEF-ko-ermB
pBT2 derivative harboring the PmazEF promoter and the transcriptional 
terminator downstream of mazEF and a lox flanked erythromycin resistance 
cassette replacing the mazE and mazF open reading frames.
23
Table 1. Strains and plasmids used in this study. aAbbreviations are as follows: Apr, ampicillin resistant; Emr, 
erythromycin resistant; Kmr, kanamycin resistant; Tcr, tetracyclin resistant.
1 0Scientific RepoRtS |         (2019) 9:16267  | https://doi.org/10.1038/s41598-019-52731-3
www.nature.com/scientificreportswww.nature.com/scientificreports/
Germany). The eukaryotic cells were washed in PBS to remove the antimicrobials. Wells without eukaryotic 
cells were routinely run in parallel to control the efficacy of the lysostaphin/gentamicin treatment. Eukaryotic 
cells were subsequently lysed and CFU rates in lysates determined as described. For long-term survival experi-
ments, infected eukaryotic cells were cultivated in the presence of gentamicin (100 µg/ml), lysostaphin (20 µg/ml), 
and 2% FCS for up to 168 h. After 96 h, cell cultures were supplied with fresh media, 10% FCS, and antibiotics. 
Numbers of intracellular surviving bacteria were determined after 24, 96, and 168 h post lysostaphin/gentamicin 
treatment as described.
Cytotoxicity assay. EA.hy926 and HaCaT cells were seeded and infected with bacteria as described. 
Following the lysostaphin/gentamicin treatment, cells were washed once with the appropriate culture medium, 
then cultured for 24 h in fresh cell culture medium without antibiotics. Cells were detached by trypsinization and 
stained with 1 mg/mL propidium iodide (PI; Fluka, Buchs, Switzerland) for 10 min. Stained cells were washed 
with PBS, and the PI-staining of cells analyzed by fluorescence-activated cell sorting (FACS, CellQuestPro, Becton 
Dickinson, Franklin Lakes, NJ, USA).
Cell viability assay. EA.hy926 and HaCaT cells were grown for 24 hours in 96-well plates until conflu-
ent (~8 × 104 cells per well). Cell cultures were infected with bacteria, non-internalized bacteria subsequently 
removed, and infected eukaryotic cells cultivated as described in the persistence assay. Bacteria-free eukaryotic 
cell cultures served as controls. After 96 h and 168 h, respectively, 100 µl aliquots of a freshly prepared 3-(4.5-dim
ethylthiazol-2-yl)-2.5-diphenyltetrazolium bromide (MTT; Merck) solution (2.5 mg/ml MTT dissolved in PBS, 
pH 7.2) were added to the wells, and cell cultures were incubated for additional 2 h at 37 °C and 5% CO2. Medium 
and MTT solution were subsequently removed and cells solubilized in 100 µl of extraction buffer (20% sodium 
dodecyl sulfate, 30% dimethylformamide, 2% acetic acid, pH 4.7) for 3 h in the dark at room temperature and 
50 rpm. Formazan formation was quantified with an EnSight multimode plate reader and the Kaleido data acqui-
sition and analysis software (PerkinElmer, Rodgau, Germany) by measuring the light absorbance at 570 nm and 
a reference wavelength of 630 nm.
qRT-PCR analyses. Quantification of mRNA for in vitro cultivated bacteria by real-time reverse transcrip-
tion PCR (qRT-PCR) was carried out as described8. For the quantification of mRNA in intracellularly persisting 
bacteria by qRT-PCR, the following protocol was used: EA.hy926 cells were infected with bacteria as described. 
After 90 min and 96 h post lysostaphin/gentamicin treatment, respectively, Ea.hy926 cells were washed once with 
PBS and subsequently lysed with ice-cold H2O supplemented with RNA protect (Qiagen, Hilden, Germany) by 
pipetting. Lysates from 5 wells were pooled and centrifuged for 15 min at 5600 × g and 4 °C. Cell pellets were sus-
pended in ice-cold TE (10 mM Tris/HCl, 1 mM EDTA pH 8.0) and bacteria were disrupted, total RNA isolated, 
and qRT-PCRs carried out as described8 using the primers listed in Table 2. The level of mRNA was normalized 
against the internal control gyrB. Transcript amounts were expressed as the fold difference relative to the control 
(2ΔΔCT where ΔCT represents the difference in threshold cycle between the target and control genes).
Statistical analyses. The statistical significance of changes between groups was assessed with Kruskal Wallis 
tests followed by Dunn’s post-hoc tests (3 and more groups) or the Mann-Whitney U test (two groups) using the 
GraphPad software package Prism 6.01. P values < 0.05 were considered significant.
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding 
author on reasonable request.
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Primer Sequence (5′-3′)a
Cloning primer
MBH325 gtcggtacCGGATTACTTATTTCTGTTATGG (KpnI)
MBH326 ggtctcgaGATTCTAATTTTGTATGTCTTGATTG (XhoI)
qRT-PCR primer
gyrB for GACTGATGCCGATGTGGA
gyrB rev AACGGTGGCTGTGCAATA
hla for AACCCGGTATATGGCAATCAACT
hla rev CTGCTGCTTTCATAGAGCCATTT
RNAIII for AGGAGTGATTTCAATGGCACAAG
RNAIII rev TGTGTCGATAATCCATTTTACTAAGTC
spa for TGCTGACAAAATTGCTGCAGATA
spa rev GCATGGTTTGCTGGTTGCTT
Table 2. Primers used in this study. aRestriction sites are underlined and specified in parentheses. Linker 
nucleotides are given as small letters.
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